NeoBase 2 Non-derivatized Assay Solutions - NeoBase™ 2 Non-derivatized Assay Solutions are - Wallac Oy

Duns Number:540156544

Device Description: NeoBase™ 2 Non-derivatized Assay Solutions are intended for in vitro diagnostic use with t NeoBase™ 2 Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase 2 Non-derivatized MSMS kit to extract target analytes from blood samples dried on filter paper and to carry target analytes to the MSMS system.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

3045-0010

Brand Name

NeoBase 2 Non-derivatized Assay Solutions

Version/Model Number

3045-0010

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K173568

Product Code Details

Product Code

NQL

Product Code Name

System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry

Device Record Status

Public Device Record Key

35dab8d3-b71d-41be-998f-d87a26fead89

Public Version Date

April 30, 2020

Public Version Number

2

DI Record Publish Date

February 25, 2019

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"WALLAC OY" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 57
2 A medical device with a moderate to high risk that requires special controls. 38
3 A medical device with high risk that requires premarket approval 2